MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer

Disease Sites:

Not Available

Staging:

Phase II/III

Age Group:

Adults

Therapies:

Mol. targeted/Immunotherapy/Biologics

Drugs:

Not Available

Principal Investigator(s):

Schaffer, Kerry

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

03-07-2025

Trial Type:

Treatment

Protocol ID:

ALLUROA032103

National Clinical Trial ID:

NCT05987241

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available